https://www.targetedonc.com/view/fda-approves-liso-cel-car-t-cell-therapy-for-relapsed-refractory-large-b-cell-lymphoma
The above link is to an announcement of an FDA approval of a CarT drug after a phase 1 trial. Check out the percentage of adverse events (79%), leading to 7 deaths. 53% CR. But still better for the patient cohort than not using this treatment. CarT approvals are moving much faster than other cancer drug discovery.
Also remember that over 40% of the CHM share register is held in Escrow for the next 23 months. So not a lot of free float if someone wants a large purchase.
CLTX-CAR T is a game changer, page-5
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1150000 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 52523 | 2 |
View Market Depth
| Last trade - 10.32am 12/08/2024 (20 minute delay) ? |
| CHM (ASX) Chart |
Day chart unavailable